Science

The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.

A recent study demonstrated the potential effects of Vitamin E, in the form of tocotrienols, on memory formation and other cognitive functions.

Results showed that both doses of krill oil significantly reduced TEWL, and increased hydration as well as elasticity compared to placebo.

Helaina has launched an ingredient called effera, which it claims is the first human lactoferrin equivalent manufactured using precision fermentation.

A recently published study, originally covered by our sister brand Cannabis Science and Tecnology, demonstrated the neuroprotective properties of the supplement N-Acetylcysteine against the effects of cannabis exposure in adolescence.

Sirio Pharma has announced that its Ubidecarenone Chewable Gels have been added to the United States Pharmacopoeia (USP) monograph.

A recent published study investigated the impacts of pentadecanoic acid (C15:0) on obese participants.

Seraphina Therapeutics has announced a partnership with Genova Diagnostics to introduce the Fatty15 C15:0 Test.

A study comparing lion’s mane mushroom and guayusa extracts tested cognition, mood, and happiness in participants.

Study shows the safety and tolerability of the beetroot extract Sabeet. Researchers also observed a trend for elevated nitrate level and reduced insulin levels.

Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.

A recently published study found that Ahiflower oil from the seeds of Buglossoides arvensis may improve plasma eicosapentaenoic acid (EPA) levels.

A recently published study found that a novel keratin-based formulation called Keragen-IV from AIDP Inc. was able to support the skin and hair health in women.

A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.

In the study, the probiotic was used as an adjunct to standard treatment, and was found to support recovery.

The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.

A recent study found that a non-genetically modified, wild-type fructanase preparation manufactured by Bio-Cat as Optiziome Fructanase (previously known as Optiziome Inulinase) was well-tolerated and safe, compared to placebo.

Results showed that children taking a gummy supplement containing EpiCor saw significantly less symptom severity when they contracted the cold or flu and also consumed less cold medication.

A 2013 study published in BMC Medicine titled “DNA barcoding detects contamination and substitution in North American herbal products,” has been retracted by the publication’s editor.

Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.

A recent study found that a novel blend of probiotics may modulate estrogen levels in healthy peri- and post-menopausal women.

The magnesium L-threonate used in the study is marketed as Magtein by ThreoTech and distributed by AIDP. The study was conducted by neuroscientists from Neurocentria and Tsinghua University.

The branded palmitoylethanolamide (PEA) ingredient called Levagen+ significantly improved dynamic lower body power, and did not inhibit strength training adaptations unlike NSAIDs or other analgesics.

Findings from Brightseed and Ocean Spray's research will be presented in a poster session presented by Ocean Spray research scientists at the American Society of Nutrition’s NUTRITION 2024 conference on June 30, 2024 at 11:45 am CDT in Chicago, IL.

According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.